|
|
|
|
|
文献清单:2025编辑精选文章(二)| MDPI Vaccines |
|
|
期刊名:Vaccines
期刊主页:https://www.mdpi.com/journal/vaccines
2025 编辑精选文章(二)收录了2025年第二季度发表于本刊的13篇高质量研究成果。全面覆盖新型疫苗技术平台创新、特定人群免疫应答评估、免疫保护机制解析、传染病公共卫生防控及疫苗安全性研究等多个核心维度,涉及呼吸道合胞病毒(RSV)、人乳头瘤病毒(HPV)、黄病毒、非洲猪瘟病毒、新冠病毒及人类 α 疱疹病毒等多种重要病原体。这些成果反映了当前疫苗学与传染病领域的前沿动态,为全球科研人员、临床医生及公共卫生工作者提供了高质量的学术参考与实践指导。
The Application of mRNA Technology for Vaccine Production—Current State of Knowledge
mRNA 技术在疫苗生产中的应用 —— 研究现状
https://www.mdpi.com/2076-393X/13/4/389
Paczkowska, A.; Hoffmann, K.; Andrzejczak, A.; Pucek, W.F.; Kopciuch, D.; Bryl, W.; Nowakowska, E.; Kus, K. The Application of mRNA Technology for Vaccine Production—Current State of Knowledge. Vaccines 2025, 13, 389. https://doi.org/10.3390/vaccines13040389
Neutralizing Antibody Response to the AreXvy Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients: Assessment Against Reference and Seasonal Strains
肺移植受者对AreXvy呼吸道合胞病毒疫苗的中和抗体反应:针对参考株与流行株的评估
https://www.mdpi.com/2076-393X/13/4/398
Levy, L.; Yahav, D.; Benzimra, M.; Bezalel, Y.; Hoffman, T.; Shirin, N.; Sinai, T.; Jurkowicz, M.; Deri, O.; Matalon, N.; et al. Neutralizing Antibody Response to the AreXvy Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients: Assessment Against Reference and Seasonal Strains. Vaccines 2025, 13, 398. https://doi.org/10.3390/vaccines13040398
HPV Vaccine Delivery Strategies to Reach Out-of-School Girls in Low- and Middle-Income Countries: A Narrative Review
中低收入国家覆盖失学女童的 HPV 疫苗递送策略:一项叙述性综述
https://www.mdpi.com/2076-393X/13/5/433
Rosser, E.N.; Wysong, M.D.; Rosen, J.G.; Limaye, R.J.; Park, S. HPV Vaccine Delivery Strategies to Reach Out-of-School Girls in Low- and Middle-Income Countries: A Narrative Review. Vaccines 2025, 13, 433. https://doi.org/10.3390/vaccines13050433
Maternal Immunization: Current Evidence, Progress, and Challenges
孕产妇免疫:现有证据、进展与挑战
https://www.mdpi.com/2076-393X/13/5/450
Santilli, V.; Sgrulletti, M.; Costagliola, G.; Beni, A.; Mastrototaro, M.F.; Montin, D.; Rizzo, C.; Martire, B.; Miraglia del Giudice, M.; Moschese, V., on behalf of the Italian Society of Pediatric Allergy and Immunology (SIAIP) Vaccine Committee. Maternal Immunization: Current Evidence, Progress, and Challenges. Vaccines 2025, 13, 450. https://doi.org/10.3390/vaccines13050450
From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity
从抗体到免疫:评估黄病毒保护和交叉反应的相关性
https://www.mdpi.com/2076-393X/13/5/449
Flores, H.E.; Pinzon Burgos, E.F.; Camacho Ortega, S.; Heredia, A.; Chua, J.V. From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity. Vaccines 2025, 13, 449. https://doi.org/10.3390/vaccines13050449
Generation of Chimeric African Swine Fever Viruses Through In Vitro and In Vivo Intergenotypic Gene Complementation
通过体外和体内基因型间基因互补制备非洲猪瘟嵌合病毒
https://www.mdpi.com/2076-393X/13/5/462
Kitamura, T.; Masujin, K.; Ikezawa, M.; Ambagala, A.; Kokuho, T. Generation of Chimeric African Swine Fever Viruses Through In Vitro and In Vivo Intergenotypic Gene Complementation. Vaccines 2025, 13, 462. https://doi.org/10.3390/vaccines13050462
Dengue Vaccine Development and Deployment into Routine Immunization
登革热疫苗研发及其在常规免疫中的推广应用
https://www.mdpi.com/2076-393X/13/5/483
Wilder-Smith, A.; Cherian, T.; Hombach, J. Dengue Vaccine Development and Deployment into Routine Immunization. Vaccines 2025, 13, 483. https://doi.org/10.3390/vaccines13050483
Addressing the Underestimated Burden of RSV in Older Adults in Europe: Epidemiology, Surveillance Gaps, and Public Health Implications
应对欧洲老年人中被低估的呼吸道合胞病毒(RSV)疾病负担:流行病学、监测差距与公共卫生意义
https://www.mdpi.com/2076-393X/13/5/510
D’Ambrosio, F.; Lomazzi, M.; Moore, M.; Maida, A.; Ricciardi, R.; Munno, L.; Lettieri, M.; De Vito, E.; Ricciardi, W.; Calabrò, G.E. Addressing the Underestimated Burden of RSV in Older Adults in Europe: Epidemiology, Surveillance Gaps, and Public Health Implications. Vaccines 2025, 13, 510. https://doi.org/10.3390/vaccines13050510
Past, Present, and Future of Viral Vector Vaccine Platforms: A Comprehensive Review
病毒载体疫苗平台的过去、现在与未来:一项全面综述
https://www.mdpi.com/2076-393X/13/5/524
Tang, J.; Amin, M.A.; Campian, J.L. Past, Present, and Future of Viral Vector Vaccine Platforms: A Comprehensive Review. Vaccines 2025, 13, 524. https://doi.org/10.3390/vaccines13050524
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville Cohort
COVID-19 mRNA 疫苗在全程接种者与突破性感染者中诱导的黏膜及血清中和免疫反应:来自路易斯维尔队列的纵向研究
https://www.mdpi.com/2076-393X/13/6/559
Batra, L.; Saxena, D.; Poddar, T.; Zahin, M.; Amraotkar, A.; Bezold, M.M.; Kitterman, K.T.; Deitz, K.A.; Lasnik, A.B.; Keith, R.J.; et al. Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville Cohort. Vaccines 2025, 13, 559. https://doi.org/10.3390/vaccines13060559
Adjuvanted RNA Origami—A Tunable Peptide Assembly Platform for Constructing Cancer Nanovaccines
佐剂化 RNA 折纸 —— 一种用于构建癌症纳米疫苗的可调控肽组装平台
https://www.mdpi.com/2076-393X/13/6/560
Yip, T.; Tu, X.; Qi, X.; Yan, H.; Chang, Y. Adjuvanted RNA Origami—A Tunable Peptide Assembly Platform for Constructing Cancer Nanovaccines. Vaccines 2025, 13, 560. https://doi.org/10.3390/vaccines13060560
Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer’s Disease, and the Potential Benefits of Targeted Treatment or Vaccination—A Virological Perspective
人类 α 疱疹病毒(HSV1、HSV2 与 VZV)感染、阿尔茨海默病及靶向治疗或疫苗接种的潜在获益 —— 病毒学视角
https://www.mdpi.com/2076-393X/13/6/572
Maple, P.A.C.; Hosseini, A.A. Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer’s Disease, and the Potential Benefits of Targeted Treatment or Vaccination—A Virological Perspective. Vaccines 2025, 13, 572. https://doi.org/10.3390/vaccines13060572
VITT Pathophysiology: An Update
疫苗诱发免疫血栓性血小板减少症(VITT)病理生理学:最新进展
https://www.mdpi.com/2076-393X/13/6/650
Petito, E.; Gresele, P. VITT Pathophysiology: An Update. Vaccines 2025, 13, 650. https://doi.org/10.3390/vaccines13060650
期刊介绍
主编:Prof. Dr. Ger Rijkers
Vaccines (ISSN: 2076-393X, IF: 3.4)是国际权威开放获取英文学术期刊,全面收录实验室和临床疫苗的研究、利用和免疫相关成果。被 SCIE (Web of Science)、Scopus、PubMed 等主流数据库广泛收录。期刊下设 15 个栏目,均由该领域顶尖科学家担任栏目主编,联合全球资深学者组成编委团队,严格把控论文学术质量,引领专题前沿发展方向。
2025 Impact Factor:3.5
2025 CiteScore:7.7
Time to First Decision:17.5 Days
Acceptance to Publication:2.8 Days
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。